MEDICINE FOR PREVENTING POSTOPERATIVE ASTIGMATISM - Santen Pharmaceutical Co., Ltd.

Title:

MEDICINE FOR PREVENTING POSTOPERATIVE ASTIGMATISM

Document Type and Number:

Japanese Patent JP3118584

Kind Code:

B2

Abstract:

PURPOSE: To obtain a medicine useful for preventing the postoperative astigmatism.
CONSTITUTION: This medicine for preventing the postoperative astigmatism contains lactoferrin as an active ingredient. The preferable form of the medicine is an opthalmic preparation, and the preferable concentration of the lactoferrins is 0.1-1.0w/v%.

More Like This:

JP2022508512	Acupuncture point delivery of steroids and macromolecules
JP2023530084	4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N- Synthetic method for the preparation of prop-2-ynyl-1,3-thiazol-2-amine
WO/2014/083613	PERITONEAL DIALYSIS FLUID

Inventors:

Mitsufumi Hikita
Narumi Hayashi

Application Number:

JP10923995A

Publication Date:

December 18, 2000

Filing Date:

May 08, 1995

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Santen Pharmaceutical Co., Ltd.

International Classes:

A61K9/08; A61K9/00; A61K38/16; A61K38/40; A61P27/02; A61P41/00; (IPC1-7): A61K38/16; A61K9/08; A61P27/02; A61P41/00

Domestic Patent References:

JP1265951A

Other References:

【文献】国際公開92/8477(WO,A1)

Attorney, Agent or Firm:

Eisuke Kishimoto (3 others)

Previous Patent: ボタン多段位置決め式単方向コードリール

Next Patent: STAIR MAT AND MANUFACTURE THEREOF